Business Description
Arovella Therapeutics is an Australian biotechnology company focused on developing new cancer treatments for patients both domestically and around the world. Its main research programs are building on cell-based therapies that can be prepared in advance and used across multiple patients, targeting several hard-to-treat cancers including blood cancers, stomach cancer, and solid tumors. Founded in 1999 and headquartered in Preston, Australia, the company was previously known as Suda Pharmaceuticals before rebranding in 2021.
